Metformin Milpharm

Metformin, the active ingredient in Metformin Milpharm, is a biguanide presented as an oral tablet for oral use. It reduces elevated blood glucose levels and is indicated for the management of type 2 diabetes mellitus in adult patients.

GNH USA supplies Metformin Milpharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU regulatory standards and is manufactured under strict quality controls. It provides a reliable source of essential antidiabetic therapy for healthcare systems across multiple regions.

Metformin Milpharm is used in the management of disorders related to impaired glucose metabolism, primarily type 2 diabetes mellitus. - Type 2 diabetes mellitus: lowers fasting plasma glucose and HbA1c, helping achieve glycemic targets. - Prediabetes: reduces progression to type 2 diabetes by improving insulin sensitivity. - Polycystic ovary syndrome: improves insulin resistance and may help regulate menstrual cycles.

Metformin may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or loss of appetite. - Diarrhea: loose stools that may be watery. - Metallic taste: transient alteration in taste perception. - Vitamin B12 deficiency: reduced absorption leading to low levels over long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal accumulation of lactate. - Severe hypoglycemia: when combined with insulin or secretagogues. - Skin reactions: rash, erythema, or Stevens‑Johnson syndrome.

Before initiating Metformin Milpharm, healthcare professionals should consider several precautionary measures. - Renal function assessment: evaluate eGFR and avoid use in severe renal impairment. - Lactic acidosis risk: contraindicated in patients with significant hepatic disease or hypoxia. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Pregnancy and lactation: discuss potential risks and benefits with the prescriber. - Drug interactions: review concomitant medications for agents that may increase metformin levels. - Store at ambient temperature: keep in original container, protect from moisture and heat.

Metformin Milpharm can interact with other medicines, affecting its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast media: may precipitate renal dysfunction and increase lactic acidosis risk. - Cimetidine: can raise metformin plasma concentrations. - Nitrates: concurrent use may enhance hypotensive effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask symptoms of hypoglycemia. - Thiazide diuretics: can attenuate glucose‑lowering effect. - ACE inhibitors or ARBs: require monitoring of renal function and electrolytes.